Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIODESIX INC Director's Dealing 2021

Jul 2, 2021

34472_dirs_2021-07-01_798587e8-8289-4f38-a8fa-ad49779b469b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIODESIX INC (BDSX)
CIK: 0001439725
Period of Report: 2021-06-29

Reporting Person: Franchi Jean M. (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-06-29 Restricted Stock Units $ A 20044 Acquired Common Stock (20044) Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

F2: These restricted stock units will vest in full on March 31, 2022 and have no expiration date.